Deborah Miller
General Counsel chez NUVALENT, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Deborah Miller is currently working as the Secretary & Chief Legal Officer at Nuvalent, Inc. Prior to her current position, she held the role of Chief IP Counsel & Deputy General Counsel at Sumitomo Pharma America, Inc. from 2017 to 2020.
She also worked as an Associate at Nutter McClennen & Fish LLP.
From 2010 to 2017, Deborah served as the Vice President & Chief Patent Counsel at Infinity Pharmaceuticals, Inc. Additionally, she was the Senior Vice President & Chief IP Counsel at Sumitomo Dainippon Pharma America, Inc. from 2020 to 2021.
Deborah's educational background includes a doctorate degree from Harvard University, an undergraduate degree from Swarthmore College, a graduate degree from Harvard Medical School, and a graduate degree from Suffolk University Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0,06% | 04/04/2024 | 33 300 ( 0,06% ) | 3 M $ | 31/03/2024 |
Postes actifs de Deborah Miller
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | General Counsel | 01/06/2021 |
Anciens postes connus de Deborah Miller
| Sociétés | Poste | Fin |
|---|---|---|
| Sumitomo Dainippon Pharma America, Inc. | Corporate Officer/Principal | 01/06/2021 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/04/2020 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2017 |
Nutter McClennen & Fish LLP
 Nutter McClennen & Fish LLP Miscellaneous Commercial ServicesCommercial Services Nutter McClennen & Fish LLP provides legal services. The firm serves to banking and financial services, energy, food and beverage, government entities, health care, information and technology, life science and manufacturing industries. The company was founded by Louis D. Brandeis and Samuel D. Warren in 1879 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Deborah Miller
| Harvard University | Doctorate Degree |
| Swarthmore College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| Suffolk University Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| NUVALENT, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Nutter McClennen & Fish LLP
Nutter McClennen & Fish LLP Miscellaneous Commercial ServicesCommercial Services Nutter McClennen & Fish LLP provides legal services. The firm serves to banking and financial services, energy, food and beverage, government entities, health care, information and technology, life science and manufacturing industries. The company was founded by Louis D. Brandeis and Samuel D. Warren in 1879 and is headquartered in Boston, MA. | Commercial Services |
| Sumitomo Dainippon Pharma America, Inc. |
